Search Results - "Miljić, P"

Refine Results
  1. 1
  2. 2

    Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism by Miljic, P., Gvozdenov, M., Takagi, Y., Takagi, A., Pruner, I., Dragojevic, M., Tomic, B., Bodrozic, J., Kojima, T., Radojkovic, D., Djordjevic, V.

    Published in Journal of thrombosis and haemostasis (01-04-2017)
    “…Essentials Prothrombin Belgrade mutation leads to antithrombin resistance. Clinical and biochemical phenotypes in a large family with this mutation were…”
    Get full text
    Journal Article
  3. 3

    Proliferative characteristics of Philadelphia‐negative myeloproliferative neoplasms ‐ clinical implications by Šefer, D., Bižić‐Radulović, S., Kraguljac‐Kurtović, N., Bogdanović, A., Čokić, V., Miljić, P., Beleslin‐Čokić, B., Knežević, V., Mitrović‐Ajtić, O., Leković, D., Gotić, M.

    “…Summary Introduction Philadelphia‐negative myeloproliferative neoplasms (Ph−MPN) are characterized by overproduction of one or more blood cell lines. Methods…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Growth hormone replacement normalizes impaired fibrinolysis: New insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency by Miljic, D, Miljic, P, Doknic, M, Pekic, S, Stojanovic, M, Cvijovic, G, Micic, D, Popovic, V

    Published in Growth hormone & IGF research (01-12-2013)
    “…Abstract Background Cardiovascular morbidity in adult patients with growth hormone deficiency (GHD) and hypopituitarism is increased. Clustering of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndrome by BECAREVIC, M, ANDREJEVIC, S, MILJIC, P, BONACI-NIKOLIC, B, MAJKIC-SINGH, N

    Published in Clinical and experimental rheumatology (01-05-2007)
    “…The link between specific antibodies and atherogenesis in primary antiphospholipid syndrome (PAPS) is less strong than for thrombosis, although clearly the two…”
    Get full text
    Journal Article
  9. 9

    Multiorgan thrombotic disorder in a young patient with primary antiphospholipid syndrome (APS) and ovarian tumor by Jeremic, K, Stefanovic, A, Ljubic, A, Miljic, P, Stojnic, J, Kastratovic, B, Arsenijevic, L J

    “…Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening condition with high mortality rate besides aggressive multimodal treatment. Underlying…”
    Get more information
    Journal Article
  10. 10

    Antiribosomal-P protein antibodies in a patient with systemic lupus erythematosus and non-Hodgkin’s lymphoma: more than coincidental finding? by Miljic, P, Bonaci-Nikolic, B, Colovic, N, Terzic, T, Colovic, M

    Published in Lupus (01-01-2009)
    “…Patients with systemic lupus erythematosus (SLE) are at an increased risk of lymphomas, but mechanisms underlying this association are obscure. Recently, it…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    The Prothrombin Factor II G20210A Mutation with Pulmonary Thromboembolism and a Normal Level of Fibrin Degradation Products by Nagorni-Obradovic, Lj, Miljic, P, Djordjevic, V, Pešut, D, Jovanovic, D, Stojsic, J, Stevic, R, Radojkovic, D

    Published in Balkan journal of medical genetics (01-01-2009)
    “…Diagnosis of pulmonary thromboembolism (PTE) usually includes clinical pretest probability assessment, testing for specific degradation products of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    New approach of the treatment of von Willebrand's disease during pregnancy by Gojnic, Miroslava, Fazlagic, A, Likic, I, Stefanovic, A, Vidakovic, S, Pervulov, M, Petkovic, S, Mostic, T, Miljic, P, Bogdanovic, A

    Published in Archives of gynecology and obstetrics (01-11-2005)
    “…The aim of the study was to analyze the effectiveness of the application of DDAVP (desmopressin) and Hemate P with cryoprecipitate pre- and postpartum in…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20